tiprankstipranks
Trending News
More News >
ONO Pharmaceutical Co Ltd (OPHLF)
OTHER OTC:OPHLF
US Market

ONO Pharmaceutical Co (OPHLF) Income Statement

Compare
17 Followers

ONO Pharmaceutical Co Income Statement

Last quarter (Q4 2024), ONO Pharmaceutical Co's total revenue was ¥112.31B, a decrease of -0.41% from the same quarter last year. In Q4, ONO Pharmaceutical Co's net income was ¥-6.54B. See ONO Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
¥ 486.87B¥ 502.67B¥ 447.19B¥ 361.36B¥ 309.28B
Gross Profit
¥ 338.92B¥ 375.55B¥ 337.13B¥ 267.85B¥ 223.71B
Operating Expenses
¥ 275.54B¥ 212.44B¥ 184.83B¥ 164.65B¥ 125.38B
Depreciation and Amortization
¥ 26.89B¥ 18.14B¥ 17.45B¥ 17.72B¥ 15.82B
EBITDA
¥ 91.42B¥ 181.98B¥ 161.11B¥ 128.54B¥ 114.54B
Operating Income
¥ 63.38B¥ 163.10B¥ 141.96B¥ 103.19B¥ 98.33B
Other Income/Expenses
¥ -4.18B¥ 630.00M¥ -8.76B¥ 1.83B¥ 2.56B
Pretax Income
¥ 59.20B¥ 163.73B¥ 143.53B¥ 105.03B¥ 100.89B
Net Income
¥ 50.05B¥ 127.98B¥ 112.72B¥ 80.52B¥ 75.42B
Per Share Metrics
Basic EPS
¥ 106.55¥ 266.61¥ 230.85¥ 162.19¥ 151.11
Diluted EPS
¥ 106.41¥ 266.60¥ 230.79¥ 162.16¥ 151.09
Weighted Average Shares Outstanding
469.69M 480.01M 488.30M 496.46M 499.14M
Weighted Average Shares Outstanding (Diluted)
469.77M 480.04M 488.35M 496.53M 499.20M
Currency in JPY

ONO Pharmaceutical Co Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis